Douglas Kwon
Director of Clinical Operations · Ragon Institute of MGH, MIT and Harvard
Credentials: · · · · ·
History
- 2007–2009
- 2005–2006
New York and Presbyterian Hospital
2004–2005
Research
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Cell · 2000 · 1,900 citations
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Science · 2010 · 997 citations
Immunity · 2015 · Last of 19 authors · Corresponding · 598 citations
- BW
20 papers
20 papers
- KD
13 papers
- SB
11 papers
- MA
9 papers · 3 as a resident
- FS
8 papers
- MS
8 papers
- AS
7 papers · 4 as a resident
Grants
- 2024–2029
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.4M · Massachusetts General Hospital
- 2022–2027
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.5M · Massachusetts General Hospital
- 2020–2025
Mechanisms of HIV-Associated Epithelialintestinal Stem Cell (ISC) Dysfunction
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.6M · Massachusetts General Hospital
- 2018–2024
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $4.1M · Massachusetts General Hospital
Clinical trials
- 2018–2022
SHIFT: Studying HIV Immunology After Fecal Transplant
Principal investigator · Withdrawn · Phase 1, Phase 2
Massachusetts General Hospital
- 2014–2016
Study chair · Completed · Phase 2
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections